Peishu FU, Fengjun SUN, Wei FENG, et al. Drug resistance of Acinetobacter baumannii and risk factors of its infection in neurosurgery[J]. Journal of Third Military Medical University, 2019, 41(7): 706-711.
DOI:
Peishu FU, Fengjun SUN, Wei FENG, et al. Drug resistance of Acinetobacter baumannii and risk factors of its infection in neurosurgery[J]. Journal of Third Military Medical University, 2019, 41(7): 706-711. DOI: 10.16016/j.1000-5404.201811218.
Drug resistance of Acinetobacter baumannii and risk factors of its infection in neurosurgery
To investigate the drug resistance and the risk factors infected by
Acinetobacter baumannii
(
A. baumannii
) in neurosurgery.
Methods
2
A total of 62 cases with
A. baumannii
infection admitted in the neurosurgery of our hospital during January and December 2017 were enrolled in this study. The minimum inhibitory concentrations of common antibacterial drugs against
A. baumannii
were determined by agar dilution. The case-control study method was used to select the 174 non-
A. baumannii
infection cases as the control group
and their clinical data were collected. The risk factors of
A. baumannii
infection were analyzed by univariate analysis and multivariate logistic regression.
Results
2
A. baumannii
strains were much higher resistant to clinically used antibacterial drugs
except levofloxacin
with the resistant rates were more than 50%. Univariate analysis found that age
pre-infection length of hospital stay ≥14 d
ICU length before infection ≥7 d
GSC score≤8
APACHEⅡ score≥20
usages of 4th generation of cephalosporins
β-lactam enzyme inhibitor
carbapenems and tigecycline before infection
and mechanical ventilation and indwelling gastric tube were risk factors for
A. baumannii
infection in neurosurgery (
P
<
0.05). Multivariate regression analysis showed that the length of ICU stay before infection ≥7 d (
OR
=4.179
95%
CI
: 1.638~10.662)
APACHEⅡ score≥20 (
OR
=5.798
95%
CI
: 1.695~19.829)
mechanical ventilation (
OR
=3.726
95%
CI
: 1.571~8.840) an
d the usage of β-lactam enzyme inhibitors before infection (
OR
=3.709
95%
CI
: 1.353~10.168) were independent risk factors for the patients with
A. baumannii
infection in neurosurgery.
Conclusion
2
The resistance rate of
A. baumannii
in neurosurgery is quite high. The length of ICU stay before infection ≥7 d
APACHEⅡ score ≥20
mechanical ventilation and usage of β-lactam enzyme inhibitors before infection are independent risk factors for
A. baumannii
infection in neurosurgery.
关键词
Keywords
references
RODRÍGUEZ-BAÑO J, CISNEROS J M, FERNÁNDEZ-CUENCA F, et al. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals[J ] . Infect Control Hosp Epidemiol, 2004, 25(10): 819-824. DOI:10.1086/502302.
QURESHI Z A, HITTLE L E, O'HARA J A, et al. Colistin-resistant Acinetobacter baumannii : beyond carbapenem resistance[J ] . Clin Infect Dis, 2015, 60(9): 1295-1303. DOI:10.1093/cid/civ048.
AGODI A, VOULGARI E, BARCHITTA M, et al. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals[J ] . J Hosp Infect, 2014, 86(4): 260-266. DOI:10.1016/j.jhin.2014.02.001.
PEREZ F, HUJER A M, HUJER K M, et al. Global challenge of multidrug-resistant Acinetobacter baumannii [J ] . Antimicrob Agents Chemother, 2007, 51(10): 3471-3484. DOI:10.1128/AAC.01464-06.
ZHANG P, ZHOU Y B, HUANG Y M, et al. Risk factors and prognosis of hospital-acquired pneumonia due to multidrug-resistant Acinetobacter baumannii [J ] . Chin J Infect Chemother, 2015, 15(6): 527-532. DOI:10.3969/j.issn.1009-7708.2015.06.005.
Chinese Medical Association Branch of Neurosurgery, Chinese Neurosurgery Critical Management Collaborative Group. Expert consensus on diagnosis and treatment of severely infected patients in neurosurgery in China (2017)[J]. Natl Med JChina, 2017, 97(21): 1607-1614. DOI:10.3760/cma.j.issn.0376-2491.2017.21.005.
HORAN T C, ANDRUS M, DUDECK M A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting[J]. Am J Infect Control, 2008, 36(5): 309-332.DOI:10.1016/j.ajic.2008.03.002.
ZHANG Y, ZHOU H, YANG Q, et al. Analysis on clicinal distribution and resistance of Acinetobacter baumannii and prognosis of pneumonia cases[J ] . Chin J Microecol, 2014, 26(5): 530-533. DOI:10.13381/j.cnki.cjm.201405009.
TU S, SHAO A W, ZHU M H, et al.Clinical distribution and drug resistance of Acinetobacter baumannii and the risk factors of the infections[J ] . Chin J Microecol, 2016, 28(12):1416-1419, 1428. DOI:10.13381/j.cnki.cjm.201612014.
HU F P, GUO Y, ZHU D M, et al. Antimicrobial resistance profile of clinical isolates in hospitals across China: report from the CHINET Surveillance Program, 2017[J]. Chin J Infect Chemother, 2018, 18(3): 241-251. DOI:10.16718/j.1009-7708.2018.03.001.
ZHOU S, XU X L, FAN X, et al. Distribution and drug resistance analysis of baumanii, pseudomonas aeruginosa, staphylococcus aureus in neurosurgery[J]. Chin J Clin Rational Drug Use, 2013, 6(10): 9-11. DOI:10.3969/j.issn.1674-3296.2013.10.008.
LI Y J, PAN C Z, FANG C Q, et al. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality[J ] . BMC Infect Dis, 2017, 17(1): 371.DOI: 10.1186/s12879-017-2471-0.
LI S, ZHANG G Q, LIU Y C. Comparison of different therapeutic regimens of tigecycline in the treatment of ICU patients with pneumonia caused by extensively drug resistant Acinetobacter baumannii [J ] . Chin J Antibiot, 2018, 43(2):139-145. DOI:10.13461/j.cnki.cja.006170.
JU M H, HOU D N, CHEN S, et al. Risk factors for mortality in ICU pat ients with Acinetobacter Baumannii ventilator-associated pneumonia: impact of bacterial cytotoxicity[J ] . J Thorac Dis, 2018, 10(5): 2608-2617. DOI:10.21037/jtd.2018.04.86.
UWINGABIYE J, LEMNOUER A, BAIDOO S, et al. Intensive care unit-acquired Acinetobacter baumannii infections in a Moroccan teaching hospital: epidemiology, risk factors and outcome[J ] . Germs, 2017, 7(4): 193-205. DOI:10.18683/germs.2017.1126.
HUANG H P, CHEN B R, LIU G, et al. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii [J ] . BMC Infect Dis, 2018, 18(1): 11. DOI:10.1186/s12879-017-2932-5.
SULTAN A M, SELIEM W A. Identifying risk factors for healthcare-associated infections caused by carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit[J ] . Sultan Qaboos Univ Med J, 2018, 18(1): e75-e80.DOI: 10.18295/squmj.2018.18.01.012.
ROCA I, ESPINAL P, VILA-FARRÉS X, et al. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace[J ] . Front Microbiol, 2012, 3: 148. DOI: 10.3389/fmicb.2012.00148.